Physician profile
Maansi V Doshi
NPI 1376842997
$2,710.51
in general payments reported to CMS, 2019-2025
15 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,624 · 2020: $122 · 2021: $405 · 2022: $150 · 2023: $53.34 · 2024: $17.63 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,183.16 | 2019-2025 | Scopis Ent, Xpress Loprofile, Audion Et Dilation System |
| Acclarent, INC | $141.58 | 2019-2021 | |
| Smith+Nephew, INC. | $89.04 | 2019-2025 | Halo, Tula |
| Regeneron Healthcare Solutions, INC. | $51.21 | 2025 | Dupixent |
| Inspire Medical Systems, INC. | $35.64 | 2025 | Inspire |
| Integra Lifesciences Corporation | $30.14 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Astrazeneca Pharmaceuticals LP | $29.01 | 2025 | Tezspire |
| Glaxosmithkline, LLC. | $26.36 | 2025 | Nucala |
| Aerin Medical INC. | $21.99 | 2023 | |
| Itamar Medical INC | $20.31 | 2025 | Watchpatone |
| Optinose US, INC. | $20.08 | 2025 | |
| Karl Storz Endoscopy-America | $17.95 | 2025 | |
| Dusa Pharmaceuticals, INC. | $15.97 | 2019 | |
| Sun Pharmaceutical Industries INC. | $14.89 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maansi Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.